2025 IBD Pharmacist Virtual Symposium
The Future of IBD Therapy: Expert Perspectives on Biosimilars
Alan C. Moss, MD, FACG, FEBG, AGAF, FRCPI
Ross M. Maltz, MD
Melissa Kirkpatrick, PharmD, BCACP
Pathogenesis of IBD
Michele Rubin, APN, CNS, CGRN
Psychosocial Issues in IBD
Alyse Bedell, PhD
The Role of the RD in IBD Clinic
Lauren Bintz, RD, CDN
Medical Therapies in IBD: Parts 1 & 2
Jenny S. Sauk, MD
Scripps Conference: New Advances in Inflammatory Bowel Disease
Nutrition for IBD
Lori Beeken, MS, RDN
Managing Pregnancy in IBD
Brigid S. Boland, MD
Panel Discussion - Collins, Ferrari
Angelina Collins, MSN, ANP-BC
Melissa J. Ferrari, PA-C, MPAS
PROactive isn’t PRO-science: When scientists go rogue!
Siddharth Singh, MD
DEBATE: To Do Proactive Therapeutic Drug Monitoring or Not?
Ryan W. Stidham, MD, MSc
IBD 101
Suresh Pola, MD
Approaching Escalation with Confidence – the evaluation and analysis of treatment change
Nutritional Therapies in IBD
Mazer Ally, MD, FAGA, FACG
Positioning Therapies for Moderate to Severe CD
Marla C Dubinsky, MD
Cancer Surveillance (and Prevention!) in IBD
Millie D. Long, MD, MPH
Loading...
We're glad to see you're enjoying Crohn's Colitis Professional… but how about a more personalized experience?
Press cancel to remain on Crohn's Colitis Professional. Press the link below or the continue button to keep going.